These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22222692)

  • 1. Overview of muscarinic receptor subtypes.
    Eglen RM
    Handb Exp Pharmacol; 2012; (208):3-28. PubMed ID: 22222692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
    Eglen RM
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor agonists and antagonists: effects on inflammation and immunity.
    Verbout NG; Jacoby DB
    Handb Exp Pharmacol; 2012; (208):403-27. PubMed ID: 22222708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor agonists and antagonists: effects on ocular function.
    Mitchelson F
    Handb Exp Pharmacol; 2012; (208):263-98. PubMed ID: 22222703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic agonists and antagonists: effects on the urinary bladder.
    Sellers DJ; Chess-Williams R
    Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic agonists and antagonists: effects on gastrointestinal function.
    Ehlert FJ; Pak KJ; Griffin MT
    Handb Exp Pharmacol; 2012; (208):343-74. PubMed ID: 22222706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of acetylcholine release by presynaptic muscarinic autoreceptors.
    Re L
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):215-23. PubMed ID: 10797864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptor agonists and antagonists: effects on keratinocyte functions.
    Grando SA
    Handb Exp Pharmacol; 2012; (208):429-50. PubMed ID: 22222709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic acetylcholine receptors as CNS drug targets.
    Langmead CJ; Watson J; Reavill C
    Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
    Honda H; Tomizawa M; Casida JE
    J Agric Food Chem; 2007 Mar; 55(6):2276-81. PubMed ID: 17319687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic agonists and antagonists in schizophrenia: recent therapeutic advances and future directions.
    Bolbecker AR; Shekhar A
    Handb Exp Pharmacol; 2012; (208):167-90. PubMed ID: 22222699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic pain pharmacology: realizing the promise of novel analgesics by overcoming old challenges.
    Fiorino DF; Garcia-Guzman M
    Handb Exp Pharmacol; 2012; (208):191-221. PubMed ID: 22222700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor pharmacology and circuitry for the modulation of cognition.
    Bubser M; Byun N; Wood MR; Jones CK
    Handb Exp Pharmacol; 2012; (208):121-66. PubMed ID: 22222698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors.
    Servent D; Fruchart-Gaillard C
    J Neurochem; 2009 Jun; 109(5):1193-202. PubMed ID: 19457160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective muscarinic receptor agonists and antagonists.
    Eglen RM; Watson N
    Pharmacol Toxicol; 1996 Feb; 78(2):59-68. PubMed ID: 8822036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor subtype pharmacology and physiology.
    Eglen RM
    Prog Med Chem; 2005; 43():105-36. PubMed ID: 15850824
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor ligands and their therapeutic potential.
    Eglen RM; Choppin A; Dillon MP; Hegde S
    Curr Opin Chem Biol; 1999 Aug; 3(4):426-32. PubMed ID: 10419852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
    Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A
    J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.